Mangalam Drugs & Organics Limited (BOM:532637)
India · Delayed Price · Currency is INR 31.90
-0.08 (-0.25%)
At close: Sep 25, 2026
Mangalam Drugs & Organics Market Cap
Mangalam Drugs & Organics has a market cap or net worth of 504.92 million as of September 25, 2026. Its market cap has decreased by -57.18% in one year.
Market Cap
504.92M
Enterprise Value
1.62B
Revenue
2.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
31.90
ChartMarket Cap Chart
Since May 24, 2005, Mangalam Drugs & Organics's market cap has increased from 214.36M to 504.92M, an increase of 135.54%. That is a compound annual growth rate of 4.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 504.92M | 15.62% |
| Dec 31, 2025 | 436.70M | -76.09% |
| Dec 31, 2024 | 1.83B | 17.53% |
| Dec 29, 2023 | 1.55B | -28.41% |
| Dec 30, 2022 | 2.17B | 5.87% |
| Dec 31, 2021 | 2.05B | -7.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Source Natural Foods and Herbal Supplements | 701.30M |
| Onyx Biotec | 652.76M |
| Shelter Pharma | 627.17M |
| Phaarmasia | 611.35M |
| Cian Healthcare | 565.50M |
| Rekvina Laboratories | 554.68M |
| Biofil Chemicals and Pharmaceuticals | 532.97M |
| ANG Lifesciences India | 525.86M |